FDA leader discusses breaking barriers in clinical research

Javara CEO Jennifer Byrne kicked off this series by sharing the history of CRAACO and ways to bring clinical research closer to clinical care. In the next article, Acting FDA Commissioner Janet Woodcock discusses possible pathways to improving the infrastructure, including the creation of community networks and forging relationships with local care providers to offer clinical research as a care option. Two leaders, one vision. Click the link below to read the full article:

View Article